MicroPort CardioFlow Medtech Corporation (HKG:2160)

Market Cap	2.10B
Revenue (ttm)	384.77M
Net Income (ttm)	-52.62M
Shares Out	2.41B
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,857,501
Average Volume	3,322,867
Open	0.9000
Previous Close	0.8800
Day's Range	0.8500 - 0.9000
52-Week Range	0.5800 - 1.3800
Beta	0.56
RSI	52.91
Earnings Date	May 28, 2025

About HKG:2160

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. It engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, Angelguide ti...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 430
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2160

Financial Performance

In 2024, HKG:2160's revenue was 361.57 million, an increase of 7.54% compared to the previous year's 336.22 million. Losses were -49.45 million, -89.51% less than in 2023.

Financial numbers in CNY